HTG2014-Section-Header-publications

Publications

Explore HTG publications
with our new search tool. Launch Now

Categories

Reset Categories

Filter by Topics

AACR2023 ADCC Gene Alteration adolescents ALK Angiogenesis Apoptosis Autocrine Signaling B-accute lyphoblastic seukemia B-ALL Biology of neoplasia Biomarkers Bladder Cancer Blastic plasmacytoid dandritic cell neoplasm BPDCN Blood bone Brain Breast Cancer CAR T cell therapy Cardiovascular Disease CDKN2A mutation Cell Free Plasma Cells Chemokines Circulating miRNAs clinical trial Colorectal cancer Comparison study Core Needle Biopsy COVID-19 Custom mRNA Cytokines Developmental Immunotherapy Developmental Therapeutics Diabetes Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Drug sensitivity Efficacy EHE cancer EMT Epstein-Barr ERBB3 Esophageal Cancer estrogen and progesteron receptors Exosomes extracellular miRNAs Extracellular Vesicles Feasibility FFPE FGF Ligand Trap FGFR Follicular lymphoma Gene Expression Gene Expression Profiling Gene Fusions Gene Signature Analysis Genetic Polymorphism Genitourinary cancer Glioblastoma Tumors Head and Neck Cancer Heart HER-2 HER2- HLA-E Homing HPV HR+ HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBCL Cell of Origin Assay EU HTG EdgeSeq EGFR KRAS and BRAF Mutation Assay HTG EdgeSeq Immune Response Panel HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq Immuno-Oncology Panel HTG EdgeSeq Lung Fusion Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq miRNA Whole Transcriptome Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq PATH Assay HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq System Immune Cells Immune Checkpoint Inhibitors Immune Response Immune System Immuno-Oncology Immunotherapy Integrins IOA- 244 IRP Kidney LAG3+ Liposarcoma Liquid Biopsy Liver liver liver tissue Lung lungs Lupus Lymphocytes Lymphoma lymphoma Melanoma melanoma Mesothelioma Microenvironment miRNA miRNA WTA Molecular Characterization Mouse mRNA custom mTOR signaling Multiple Myeloma MYC Natural Killer Cells Neoantigens Novel Therapeutic Targets OBP Oral cancer Oral Cancer oral squamous cell carcinoma OSCC Osteoarthritis palbociclib PALLET PALOMA PALOMA-2 PanB Pancreas Pathway Analysis Patient Stratification PAXgene PBMCs PCA Cell Lines PD-L1 PDX model PENELOPE-B PFAS PI3K inhibitors PIK3CA mutation PIP Plasma Platform Comparison Programmed cell death protein 1 Prostate Prostate Cancer qNPA qPCR Rbsig Renal Cell Carcinoma Reproductive Reveal Rheumatoid Arthritis safety Sarcoma Serum Signaling Inhibitors Signaling Pathways Signature Validation Signatures Sinonasal Carcinoma Squamous cell carcinoma STAT6 pathway Sub-typing Testicular cancer Therapeutic Response TMB Toxicity TP53 mutation Transplantation Treatment Outcome Treatment Stratification Triple Negative Breast CancerTNBC Tumor Biology Tumor Immunobiology Tumor infiltrating lymphocytes Tumor Microenvironment tumor microenvironment Urine Urothelial carcinoma VEGFR Xenograft Tissue
Reset Filter Reset All

2014

Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing

Thompson D., et al. Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing. Poster session presented at: 64th annual meeting of the American Society of Human Genetics; 2014 October 18-22; San Diego, CA

Download pdf 1.1MB

Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.

Barr P.M., et al. Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. Aug 2014 Vol 124:8.

PMID: 25016003

View External Link

Epithelial and stromal expression of miRNAs during prostate cancer progression.

Ren Q., et al. Epithelial and stromal expression of miRNAs during prostate cancer progression. Am J Transl Res. 2014 Jul 18;6(4):329-39.

PMID: 25075250

View External Link

Correlation of multiplex measurement of mRNA expression from FFPE tissues with protein expression.

Shell S., et al. Correlation of multiplex measurement of mRNA expression from FFPE tissues with protein expression. J Clin Oncol. 32, 2014;32(Suppl):abstr e22141.

View External Link

FGFR and FGF ligand overexpression in lung cancer: Implications for targeted therapy.

Maddula K., et al. FGFR and FGF ligand overexpression in lung cancer: Implications for targeted therapy. J Clin Oncol. 2014;32(Suppl 5):abstr 11080.

Download pdf 3.8MB
View External Link

Blood test to Monitor for the Absence of Acute Cardiac Rejection: From Discovery to Clinical Implementation

Hollander Z., et al. Blood test to Monitor for the Absence of Acute Cardiac Rejection: From Discovery to Clinical Implementation. J Heart Lung Transplant. 2014 Apr; 32(Suppl 4).

View External Link

RNA expression based screening of ALK Gene Fusion from NSCLC FFPE samples.

Maddula K., et al. RNA expression based screening of ALK Gene Fusion from NSCLC FFPE samples. Cancer Res. 2014;74(19 Suppl):abstr 1904. 

Download pdf 2.0MB
View External Link

In Vivo Molecular Markers for Pro-inflammatory Cytokine M1 Stage and Resident Microglia in Trimethyltin-Induced Hippocampal Injury.

McPherson C., et al. In Vivo Molecular Markers for Pro-inflammatory Cytokine M1 Stage and Resident Microglia in Trimethyltin-Induced Hippocampal Injury. Neurotox Res. 2014 Jan 25(1):45-56.

PMID: 24002884

View External Link

2013

Development of an automated RNA-based nuclease protection assay for the detection of expressed EML-ALK fusions, EGFR and KRAS mutations in NSCLC.

Rounseville M., et al. Development of an automated RNA-based nuclease protection assay for the detection of expressed EML-ALK fusions, EGFR and KRAS mutations in NSCLC. J Clin Oncol. 2013;31(Suppl); abstr e22185.

View External Link

Targeted gene expression sequencing from FFPE: NPSeq™.

Thompson D., et al. Targeted gene expression sequencing from FFPE: NPSeq™. Cancer Res. 2013;73(8 Suppl):abstr 4146.

View External Link

Page last updated May 22, 2023